After adjustment for demographic and health variables, hazard ratio was 1.94 for individuals with epilepsy and sleep ...

The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.

In an update to its guidelines for treating pediatric atopic dermatitis, the American Academy of Pediatrics noted that successful treatment involves the triad of maintenance skin care, topical ...

Female PCPs have higher earnings compared with male PCPs in value-based care, similar earnings in fee-for-service.

The median overall survival was 16.5 months with anlotinib plus penpulimab and 13.2 months with sorafenib. First-line treatment with anlotinib and penpulimab can improve survival outcomes when ...

Two patients present with pink plaques on different parts of their head and face. Can you correctly identify each case?

RxDx assay as a companion diagnostic to identify c-Met protein expression in non-squamous NSCLC patients eligible for treatment with Emrelis.

The FDA originally approved Otulfi as a biosimilar in October 2024 based on clinical data that demonstrated the product was highly similar to Stelara.

Recently we asked our readers for the best advice they’ve received as an NP or PA and what advice they would you give to newly graduated NPs or PAs. Here are some of the words of wisdom on ...